TABLE 1

Patient Demographics

ParameterTotal (n = 31)Malignant (n = 6)Benign (n = 25)P
Mean age ± SD (y)57.1 ± 14.560.8 ± 16.356.2 ± 14.2NS
Sex (F/M)19/123/316/9NS
Body mass index (kg/m2)25.0 ± 4.123.9 ± 2.825.5 ± 4.3NS
Use of alcohol (yes/no)2/290/62/23NS
Smoking (yes/no)6/251/55/20NS
History of pancreatitis (yes/no)6/250/62/23NS
Symptoms (yes/no)19/125/114/11NS
Blood chemistry
 Ca19-9 (kU/L)87 ± 263232 ± 49447 ± 156*NS
 Carcinoembryonic antigen (μg/L)2.6 ± 1.63.0 ± 2.32.5 ± 1.4NS
 Total bilirubin (μmol/L)11.9 ± 10.39.7 ± 2.612.8 ± 11.6NS
 Alkaline phosphatase (U/L)70 ± 3276 ± 5068 ± 28NS
 Alanine transferase (U/L)25 ± 1828 ± 2824 ± 15NS
 Amylase (U/L)69 ± 3153 ± 2474 ± 32NS
 γ-glutamyl transferase (U/L)45 ± 6242 ± 2846 ± 68NS
Location
 Head15213NS
 Body514NS
 Tail826NS
 Whole pancreas312NS
Size (cm)NS
 Mean ± SD5.3 ± 3.85.1 ± 4.04.8 ± 2.7
 Range1.3–182.5–181.3–10
  • * One patient with benign mucinous cystic neoplasia had Ca19-9 of 775 kU/L.

  • Two patients with main-duct IPMN.

  • NS = not statistically significant.

  • Data are numbers of patients, unless otherwise indicated.